<PAGE> 1
SCHEDULE 13D
(RULE 13d-101)
Information to be Included in Statements Filed Pursuant to Rule 13d-1(a) and
Amendments Thereto Filed Pursuant to Rule 13d-2(a)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Amendment No. 1 to
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Medtox Scientific, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock and Warrants
--------------------------------------------------------------------------------
(Title of Class of Securities)
586999-40-1
--------------------------------------------------------------------------------
(CUSIP Number)
Robert T. Montague
Robins, Kaplan, Miller & Ciresi
800 LaSalle Avenue, Suite 2800
Minneapolis, MN 55408
612-349-8500
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
December 27, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box / /.
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule
13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE> 2
CUSIP NO. 586999-40-1 13D PAGE 2 OF 9 PAGES
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(ENTITIES ONLY)
Pyramid Trading Limited Partnership 36-3723624
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
WC
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
0 Shares
SHARES -----------------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
348,300 Shares
OWNED BY EACH -----------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
REPORTING
0 Shares
PERSON -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
348,300 Shares
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
348,300 Shares
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions) [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.5%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
BD, PN, IV
--------------------------------------------------------------------------------
<PAGE> 3
CUSIP NO. 586999-40-1 13D PAGE 3 OF 9 PAGES
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(ENTITIES ONLY)
Oakmont Investments, LLC 36-3996171
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
N/A
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
0 Shares
SHARES -----------------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
348,300 Shares
OWNED BY EACH -----------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
REPORTING
0 Shares
PERSON -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
348,300 Shares
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
348,300 Shares
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions) [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.5%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
CO, IV
--------------------------------------------------------------------------------
<PAGE> 4
CUSIP NO. 5869999-40-1 13D PAGE 4 OF 9 PAGES
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(ENTITIES ONLY)
Daniel Asher, ###-##-####
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
N/A
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
348,300 Shares
SHARES -----------------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
348,300 Shares
OWNED BY EACH -----------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
REPORTING
348,300 Shares
PERSON -----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
348,300 Shares
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
348,300 Shares
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (See Instructions) [ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
9.5%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
--------------------------------------------------------------------------------
<PAGE> 5
5 of 9
CUSIP No.586999-40-1
This Amendment No. 1 ("Amendment No. 1") amends the Statement on
Schedule 13D (the "Schedule 13D") filed on September 28, 2000, by Pyramid
Trading Limited Partnership ("PT"), Oakmont Investments, LLC, the general
partner of PT ("OI") and Daniel Asher, as manager of OI and individually ("DA")
(collectively the "Reporting Persons") with respect to their beneficial
ownership of common stock, par value $.15 per share (the "Common Stock") of
Medtox Scientific, Inc., a Delaware corporation (the "Company"). The principal
executive offices of the Company are located at 402 West County Road D, St.
Paul, MN 55112. Item 5 is hereby amended to read as follows:
<PAGE> 6
6 of 9
CUSIP No.586999-40-1
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) As of 12/27/00 the Reporting Persons beneficially owned the amounts
of Common Stock and Warrant to purchase Common Stock respectively set forth
below. The percentage set forth below represents the percentage of the
outstanding shares of Common Stock based on 3,506,716 shares outstanding as of
11/13/00 as set forth in the Company's Form 10Q for the quarter ended 09/30/00
as adjusted in accordance with Rule 13D-3.
<TABLE>
<CAPTION>
Reporting Shares of Percent of
Person Common Stock Outstanding Common Stock
--------- ------------ ------------------------
<S> <C> <C>
PT, OI, DA 348,300(1) 9.5
</TABLE>
----------------
1 Includes Warrants to purchase 140,000 shares exercisable within
(sixty) 60 days.
(b) The information set forth in Items 7 through 11 of the cover pages
hereto is incorporated herein by reference.
(c) The following schedule sets forth all transactions (open market
purchases) in the Common Stock of the Company effected by the Reporting Persons
since the filing of the Schedule 13D:
Date of Purchase No. of Shares Price Per Share (net of commissions)
---------------- ------------- ------------------------------------
10/05/00 500 10.63
10/24/00 600 11.00
10/25/00 1,100 11.00
10/27/00 500 11.75
10/27/00 9,000 12.00
10/27/00 500 12.13
10/27/00 2,000 12.25
10/30/00 3,000 12.13
11/01/00 1,300 12.00
11/02/00 200 11.88
11/03/00 1,800 11.75
11/22/00 8,000 11.63
11/27/00 3,400 11.50
11/29/00 2,300 11.00
12/04/00 1,000 9.38
12/04/00 2,000 9.50
12/15/00 6,500 7.88
12/18/00 4,000 7.75
12/20/00 5,000 6.88
12/21/00 5,000 6.25
12/21/00 5,000 6.75
12/21/00 5,000 6.88
12/27/00 600 5.75
<PAGE> 7
7 of 9
CUSIP No.586999-40-1
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
1. Agreement dated as of January 4, 2001 by and among the
signatories of this Statement on Schedule 13D with respect to
its filing.
SIGNATURE
After reasonable inquiry and to the best of his knowledge and
belief, the undersigned certifies that the information set forth in this
statement is true, complete and correct.
Date: January 4, 2001 PYRAMID TRADING LIMITED PARTNERSHIP
BY: OAKMONT INVESTMENTS, LLC
ITS: GENERAL PARTNER
BY: /S/ Daniel Asher
-------------------------------
Daniel Asher
Manager, Oakmont Investments, LLC
OAKMONT INVESTMENTS, LLC
BY: /S/ Daniel Asher
-------------------------------
Daniel Asher, Manager
/s/ Daniel Asher
-----------------------------------
DANIEL ASHER
<PAGE> 8
8 of 9
CUSIP No.586999-40-1
EXHIBIT INDEX
EXHIBIT NO. DOCUMENT
1 Agreement, dated as of January 4, 2001 by and among the
signatories of this Statement with respect to its filing.
TYPE: EX-1
SEQUENCE: 2
DESCRIPTION: AGREEMENT DATED AS OF JANUARY 4, 2001
